These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37534940)

  • 1. Quantum pBac: An effective, high-capacity piggyBac-based gene integration vector system for unlocking gene therapy potential.
    Hua WK; Hsu JC; Chen YC; Chang PS; Wen KK; Wang PN; Yang WC; Shen CN; Yu YS; Chen YC; Cheng IC; Wu SC
    FASEB J; 2023 Sep; 37(9):e23108. PubMed ID: 37534940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system.
    Chang PS; Chen YC; Hua WK; Hsu JC; Tsai JC; Huang YW; Kao YH; Wu PH; Wang PN; Chang YF; Chang MC; Chang YC; Jian SL; Lai JS; Lai MT; Yang WC; Shen CN; Wen KK; Wu SC
    PLoS One; 2024; 19(8):e0309245. PubMed ID: 39190688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAR T Cell Generation by
    Bishop DC; Caproni L; Gowrishankar K; Legiewicz M; Karbowniczek K; Tite J; Gottlieb DJ; Micklethwaite KP
    Mol Ther Methods Clin Dev; 2020 Jun; 17():359-368. PubMed ID: 32071928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Saito S; Nakazawa Y; Sueki A; Matsuda K; Tanaka M; Yanagisawa R; Maeda Y; Sato Y; Okabe S; Inukai T; Sugita K; Wilson MH; Rooney CM; Koike K
    Cytotherapy; 2014 Sep; 16(9):1257-69. PubMed ID: 25108652
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Suematsu M; Yagyu S; Nagao N; Kubota S; Shimizu Y; Tanaka M; Nakazawa Y; Imamura T
    Front Immunol; 2022; 13():770132. PubMed ID: 35154098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. piggyBac transposon system modification of primary human T cells.
    Saha S; Nakazawa Y; Huye LE; Doherty JE; Galvan DL; Rooney CM; Wilson MH
    J Vis Exp; 2012 Nov; (69):e4235. PubMed ID: 23149543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.
    Manuri PV; Wilson MH; Maiti SN; Mi T; Singh H; Olivares S; Dawson MJ; Huls H; Lee DA; Rao PH; Kaminski JM; Nakazawa Y; Gottschalk S; Kebriaei P; Shpall EJ; Champlin RE; Cooper LJ
    Hum Gene Ther; 2010 Apr; 21(4):427-37. PubMed ID: 19905893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells.
    Hudecek M; Gogishvili T; Monjezi R; Wegner J; Shankar R; Kruesemann C; Miskey C; Ivics Z; Schmeer M; Schleef M
    Recent Results Cancer Res; 2016; 209():37-50. PubMed ID: 28101686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells.
    Kaštánková I; Štach M; Žižková H; Ptáčková P; Šmilauerová K; Mucha M; Šroller V; Otáhal P
    Mol Ther Methods Clin Dev; 2021 Dec; 23():119-127. PubMed ID: 34631931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in
    Morita D; Nishio N; Saito S; Tanaka M; Kawashima N; Okuno Y; Suzuki S; Matsuda K; Maeda Y; Wilson MH; Dotti G; Rooney CM; Takahashi Y; Nakazawa Y
    Mol Ther Methods Clin Dev; 2018 Mar; 8():131-140. PubMed ID: 29687032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.
    Bishop DC; Xu N; Tse B; O'Brien TA; Gottlieb DJ; Dolnikov A; Micklethwaite KP
    Mol Ther; 2018 Aug; 26(8):1883-1895. PubMed ID: 29861327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
    Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
    Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PiggyBac transposon-mediated gene transfer in human cells.
    Wilson MH; Coates CJ; George AL
    Mol Ther; 2007 Jan; 15(1):139-45. PubMed ID: 17164785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transposons: Moving Forward from Preclinical Studies to Clinical Trials.
    Tipanee J; VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1087-1104. PubMed ID: 28920716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.
    Cheng C; Tang N; Li J; Cao S; Zhang T; Wei X; Wang H
    J Med Genet; 2019 Jan; 56(1):10-17. PubMed ID: 30030293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimum internal and external sequence requirements for transposition of the eukaryotic transformation vector piggyBac.
    Li X; Lobo N; Bauser CA; Fraser MJ
    Mol Genet Genomics; 2001 Oct; 266(2):190-8. PubMed ID: 11683259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAVS1 site-specific integration of the CAR gene into human primary T cells using a linear closed-ended AAV-based DNA vector.
    Chen W; Tan L; Zhou Q; Li W; Li T; Zhang C; Wu J
    J Gene Med; 2020 Apr; 22(4):e3157. PubMed ID: 31901177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.
    Cooney AL; Singh BK; Sinn PL
    Mol Ther; 2015 Apr; 23(4):667-74. PubMed ID: 25557623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel xeno-free and serum-free culturing condition to improve piggyBac transposon-based CD19 chimeric antigen receptor T-cell production and characteristics.
    Sanyanusin M; Tudsamran S; Thaiwong R; Tawinwung S; Nishio N; Takahashi Y; Hirankarn N; Suppipat K
    Cytotherapy; 2023 Apr; 25(4):397-406. PubMed ID: 36517366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes.
    Nakazawa Y; Huye LE; Dotti G; Foster AE; Vera JF; Manuri PR; June CH; Rooney CM; Wilson MH
    J Immunother; 2009 Oct; 32(8):826-36. PubMed ID: 19752751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.